Article Figures & Data
Figures
- Figure 1.
Kaplan-Meier estimates of OS in patients in HCC with PVTT. Significant differences in OS were determined using the log-rank test. Time 0 was defined as the date of administration of systemic chemotherapies. PVTT, Portal vein tumor thrombus; ATZ+BEV, atezolizumab plus bevacizumab; HAIC, hepatic arterial infusion chemotherapy; OS: overall survival.
- Figure 2.
The change of ALBI score in ATZ+BEV and HAIC. ALBI, Albumin-bilirubin score; ATZ+BEV, Atezolizumab plus bevacizumab; HAIC, hepatic arterial infusion chemotherapy.
